Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.

NCT01886924 · ClinicalTrials.gov registry record · NA

Computer MI for Tobacco Quitline Engagement in Smokers Living With HIV

A NA study of Smoking Cessation, sponsored by Butler Hospital.

Completed
Registry status
NA
Development phase
100
Enrollment target
1
Study location

NCT01886924: Completed NA study of Smoking Cessation, sponsored by Butler Hospital.

NCT01886924 is a NA study of Smoking Cessation that has completed, run by Butler Hospital. The registered enrollment target is 100 participants, below the 474-participant average among 188 other Smoking Cessation trials with a reported enrollment target (79% lower). The trial reports 1 study location across 1 state. According to ClinicalTrials.gov, the official US trial registry.

View on ClinicalTrials.gov ↗

View your shortlist →

The verdict

NCT01886924, a NA study of Smoking Cessation, has completed, sponsored by Butler Hospital.

COMPLETED
Registry status
NA
Development phase
100 participants
Enrollment target
1
Study location

Study Summary

The long-term goal of this program of research is to disseminate an effective, brief computer-based intervention that can be readily integrated into HIV treatment settings to motivate tobacco quitline use among smokers living with HIV. The overall objective of this application is to develop this computer intervention, modify it based on initial piloting and feedback, and obtain preliminary data supporting the efficacy of the intervention. This will be accomplished by pursuing three specific aims: 1) to develop and conduct preliminary pilot testing (n=16) of a brief, computer-based intervention intended to motivate tobacco quitline use among cigarette smokers living with HIV (Computer Intervention to Motivate Engagement in Tobacco Quitline treatment; CI-METQ) and to develop and pilot (n=4) a computer-based, time matched nutrition education for PLWH control intervention (NC) equated for the offer of a tobacco quitline referral and 8 weeks of free nicotine patch for those who engage in quitline treatment, 2) to conduct a preliminary smoking cessation, randomized controlled trial (RCT) with 100 people living with HIV (PLWH) who smoke cigarettes, comparing CI-METQ vs. NC, with predictions that CI-METQ relative to NC will result in increased readiness, higher rates of tobacco treatment engagement, more quit smoking attempts and higher rates of 7-day point prevalence abstinence rates at 1-, 3- and 6-month follow-ups. Health-related quality of life over this period will also be examined, and 3) to examine CI-METQ's effects on key mechanisms during the computer session and their associations with tobacco treatment engagement and smoking outcomes at 1- and 3-month follow-ups.

Conditions Studied

Interventions

  • BEHAVIORAL Brief Computer MI for Smoking Cessation
  • BEHAVIORAL Nutrition Control

Study Locations (1)

Rhode Island

  • The Miriam Hospital - Providence

Trial Details

FieldValue
Enrollment Target 100 participants
Start Date 2014-02
Est. Completion 2015-05
Phase NA
Butler Hospital

103 total trials

What the finished NCT01886924 record still lists

NCT01886924 is an interventional study that assigns participants to a tested intervention. The registered 100 participants enrollment target is mid-sized for trials with a published cap, below the 474-participant average among 188 other Smoking Cessation trials with a reported enrollment target (79% lower).

The record links to 1 condition, with Smoking Cessation appearing as the primary indexed condition, and to 2 interventions - of which Brief Computer MI for Smoking Cessation is the first listed.

NCT01886924 reports a single indexed study location in Rhode Island.

Frequently Asked Questions

What is clinical trial NCT01886924 about?

NCT01886924 is a clinical study titled "Computer MI for Tobacco Quitline Engagement in Smokers Living With HIV". The long-term goal of this program of research is to disseminate an effective, brief computer-based intervention that can be readily integrated into HIV treatment settings to motivate tobacco quitline use among smokers living with HIV. The overall objective of this application is to develop this com...

What is the current status of trial NCT01886924?

This trial is currently completed. It is a NA study. The enrollment target is 100 participants. The study started on 2014-02. Estimated completion is 2015-05.

What conditions does trial NCT01886924 study?

This clinical trial studies the following conditions: Smoking Cessation.

What interventions are being tested in trial NCT01886924?

The interventions under investigation include: Brief Computer MI for Smoking Cessation (BEHAVIORAL), Nutrition Control (BEHAVIORAL).

Who is sponsoring clinical trial NCT01886924?

This trial is sponsored by Butler Hospital, which has 103 total clinical trials registered on ClinicalTrials.gov.

Where is trial NCT01886924 being conducted?

This trial has 1 study location across Rhode Island. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.

Similar trials for Smoking Cessation

Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.

Where NCT01886924's enrollment target sits among peer trials

100 118th of 188 higher than 71 of 188 other Smoking Cessation trials

participants (enrollment target), bucketed by value

Each bar is a band; taller bars hold more other Smoking Cessation trials. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count and share, and where it sits relative to this entry.

Source ClinicalTrials.gov registry export · 2026-08-08

Nationwide trials with similar profiles

Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.

Similar enrollment target

  • NCT01048281 · 100 participants

    Clinical & Pathological Studies of Upper Gastrointestinal Carcinoma

  • NCT01161199 · 100 participants

    The Use of Leukapheresis to Support HIV Pathogenesis Studies

  • NCT01327690 · 100 participants · Early Phase 1

    Mental Health in Veterans and Families After Group Therapies

  • NCT01730781 · 100 participants

    Imaging Cannabinoid Receptors Using Positron Emission Tomography (PET) Scanning

Similar registry start date

  • NCT05988463 · started 2027-01-01 · Phase 1

    Dose-Escalation Study of Artesunate Patients With IPF

  • NCT07219706 · started 2026-12-10 · NA

    Dietary Fiber and Time Restricted Eating

  • NCT02831335 · started 2026-12-01

    Technical Development of Multi-Parametric Renocerebral MRI

  • NCT05962346 · started 2026-12 · NA

    Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia

Source: ClinicalTrials.gov NCT01886924, the US trial registry maintained by the National Library of Medicine. NCT01886924 (mid enrollment · single site footprint · completed) retrieved and formatted by PlainTrial, see methodology.